Evestra Snags DoD Grant For Experimental Breast Cancer Drug Research

By David Holley, Xconomy San Antonio—A small Texas biotech that develops women’s health ...

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Ricardo Carrion, Jr., Ph.D. During the West African Ebola outbreak that began in 2013, an experimental ...


June 24, 2011

Topic: "New Drug Development: Orally Bioavailable Prodrugs of DNA Methyltransferase I Inhibitor Decitabine"

Speaker: William E. Bauta, PhD, Genzyme Corporation

Time: 7:30 am Registration and Breakfast Buffet, 8:00 Meeting and Speaker

Location:INCELL - 12734 Cimarron Path, San Antonio, TX 78249
(off DeZavala near IH-10; road across from Post Office; Culver's restaurant on corner)

Cost: $15 SALSA members, $20 non-members

RSVP: or (210) 877-0100


Stay informed. Subscribe to BioMed SA news alerts.